Received by email:

File: EDOCS-#113425-v1-THC_Press_Release(1).DOCX

THELON CAPITAL ANNOUNCES CHANGE OF BUSINESS: PLANS TO ACQUIRE MMPR LICENSE APPLICANTS AND OFFER RELATED TECHNOLOGIES, 
--->PRODUCTS AND SERVICES
Thelon Capital Ltd. (the "Company") (TSXV: THC) is pleased to announce that it has become engaged in the business of b
--->ecoming an MMPR licensed producer and developing and supplying technologies, products and services to support licensed
---> producers under Canada's Marihuana for Medical Purposes Regulations ("MMPR"). The Company has decided not to pursue i
--->ts option to obtain a mineral resource property interest.
The Company provides the following updates:
Acquisition of MMPR License Applicants
The Company is currently in the final stages of negotiation to acquire two private companies that have submitted licen
--->se applications to Health Canada pursuant to MMPR. 
Listing Application to the CSE
The Company has decided to list its securities for trading on the Canadian Securities Exchange ("CSE") and delist from
---> the TSXV. The Company is currently in the process of preparing its CSE listing application.
Extension of Due Diligence Period
On May 13, 2014, the Company announced that it had entered into a memorandum of understanding ("MOU") to purchase 100%
---> of a Private Federal Corporation, 8824479 Canada Inc. ("Holdco".) Holdco has the exclusive option to purchase a 30% i
--->nterest in The Cannabinoid Medical Clinic. THC has advanced $200,000 to Holdco to secure a 45-day due diligence period
---> to enter into a definitive agreement. During the due diligence period, the Company discovered that there are issues r
--->elated to the approvals that would be required for the operation of Cannabinoid Medical Clinics in certain Canadian pr
--->ovinces. On July 23, 2014, the parties agreed to extend the due diligence period until September 30, 2014.  
At this time, no transactions are in place, nor is there any assurance that any transactions will be concluded in the 
--->future. There is no assurance that the Company or any of its subsidiaries will become a licensed producer under MMPR.
ON BEHALF OF THE BOARD OF DIRECTORS
Jason Walsh, President & Chief Executive Officer
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX 
--->VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OF ACCURACY OF THIS RELEASE.
This news release contains forward-looking statements that involve risks and uncertainties. Forward-looking statements
---> or information are based on current expectations, estimates and projections that involve a number of risks and uncert
--->ainties which could cause actual results to differ materially from those anticipated by the Company. The forward-looki
--->ng statements or information contained in this news release are made as of the date hereof and the Company does not un
--->dertake any obligation to update publicly or revise any forward-looking statements or information, whether as a result
---> of new information, future events or otherwise, unless so required by applicable securities laws.
Contact:
Thelon Capital Ltd. Jason Walsh President & Chief Executive Officer (604) 682-1643 (604) 682-1666 www.theloncapital.co
--->m